University of Tampere Main building lecture hall A2A
FICAM, the Finnish Centre for Alternative Methods was founded, thanks to the financial support of Pirkanmaa ELY Centres and City of Tampere, on December 10, 2008 at the University of Tampere, School of Medicine.
FICAM focuses on development of regulatory (OECD) relevant and routine human cellular test models and approaches to be used in basic and applied research, drug development and chemical safety risk assessment.
FICAM promotes the area related to non-animal tests and approaches in many ways both nationally and internationally. We disseminate state of art technologies and information, educate experts and are active both in national and international task groups, projects and societies.
Chair, Dean Professor Tapio Visakorpi
11.00 New Tampere University Vice President for Research Juha Teperi: Welcome and opening
MEP Finland Harri Jaskari: Finland's economy strategy and FICAM
MEP European Parliament Sirpa Pietikäinen: The key developments on EU and international levels
Dr. Rob Howes, AstraZeneca GB: Utilization of in vitro methods and non-animal approaches in drug development
13.15 - 14.00 Networking and refreshments, greeting from City of Tampere
14.00 Professor Tuula Heinonen, FICAM: FICAM's activities and 3R-consortium
Case 1: Angiogenesis-vasculogenesis model
14.30 Dr. Tarja Toimela, FICAM: Test principle and applications
14.45 Dr. Anita Virtanen, PSHP: User's experience
Case 2: Inner air toxicity testing
15.00 Ms. Marika Mannerström, FICAM: Test principle and applications
15.15 Professor Mirja Salkinoja-Salonen, University of Helsinki: User's experience
15:30 Dr. Tiina Palomäki, FIMEA: Approval of non-animal tests in different regulatory requirements
16:00 Dr. Tiina Pullola, Ministry of Agriculture and Forestry: Promotion of 3Rs and FICAM
Professor Tuula Heinonen, 050 574 9705